Nexiron Injection is a medical preparation containing Iron Sucrose, with a concentration of 100mg per 5ml. It is intended for intravenous administration in adult and pediatric patients to treat iron deficiency anemia when oral iron therapy is inadequate or intolerable. Nexiron Injection should be administered under the supervision of a healthcare professional. The dosage should be individualized based on the patient's response, iron status, and concomitant therapies. Monitoring of serum iron, ferritin, and hemoglobin levels is essential during treatment to ensure appropriate dose adjustments and to detect potential adverse reactions. Common side effects include local reactions at the injection site, nausea, headache, and hypersensitivity reactions. As with all parenteral medications, proper aseptic techniques should be followed during administration to minimize the risk of infection. Consult relevant prescribing information for complete details on the safe and effective use of Nexiron Injection.